Proinflammatory Cytokines in Paraventricular Nucleus Involved in Improvement of Heart Failure by Eplerenone
DOI:
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Aim To study the effects of eplerenone (EPL) on heart failure and inflammatory cytokines in central nervous system. Methods Wistar rats were divided into sham group (n6),PDTC treatment group (n10),EPL treatment group (n10) and model group (n10). Then these rats were administrated with PDTC (150 mg/(kg·d)),EPL (30 mg/(kg·d)) and clean distilled water. After six weeks,hemodynamic data was measured,then hypothalamus and serum samples were collected. Cytokines,nuclear factor kappa B (NF-κB),corticotropin releasing hormone (CRH),aldosterone (ALD) and norepinephrine (NE) was measured. Results Eplerenone and PDTC could improve heart function. In the model group,expression of ALD,NE,TNF-α,CRH,AngⅡ and NF-κB/p65 increased. Eplerenone and PDTC decreased the expression of these indexes effectively. Expression of CRH positive neurons in the hypothalamus of rats was significantly increased in the model group,which was decreased in eplerenone and PDTC treated group. Conclusions Eplerenone could improve heart function in rats with heart failure,which may be related to the inhibition of expression of inflammatory cytokines in hypothalamic paraventricular nucleus.

    Reference
    Related
    Cited by
Get Citation

WANG Tao, LIU Qiang, YU Hua-Peng, LI Dai-Xu, and JIA Ru-Yi. Proinflammatory Cytokines in Paraventricular Nucleus Involved in Improvement of Heart Failure by Eplerenone[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2015,23(09):887-890.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:December 23,2014
  • Revised:
  • Adopted:
  • Online: July 21,2015
  • Published:
Article QR Code